US RE47,475 E1 · Selective agents for pain suppression

Abstract

In preferred embodiments, the present invention provides methods of treatment and pharmaceutical compositions for the suppression, alleviation and prevention of the often chronic, severe and debilitating pain that can accompany inflammatory diseases and neuropathic insults, pain that is often unresponsive to conventional analgesic treatment. The preferred embodiments of the present invention further relate to methods of treatment and pharmaceutical compositions using benzodiazepine derivatives that provide suppression, alleviation and prevention of neuropathic pain, migraine-related pain and inflammatory pain with reduced sedative and ataxic side effects.

Claims15

Dependent claims

A method for the treatment and suppression of neuropathic pain, inflammatory pain and migraine-associated pain comprising administering to a patient in need of such treatment an effective amount of a compound of the formula wherein the compound is

and salts thereof where R is H or Si(CH3)3, R′ is CO2CH2CH3, CO2CH(CH3)2, CO2CH2CH(CH3)2, CON(CH3)2, CONHCH3, or COSCH3 and where R′2 R2′ is CH(CH3)2, CH2CH3, or CH3.

Dependencies are inferred from the claim text.

Selective agents for pain suppression

Life of this patent

Selective agents for pain suppression

Life of this patent

Abstract

Claims15